Stop advertising claims of Coronil as COVID cure until approval: AYUSH Ministry to Patanjali

authorities ordered Patanjali to stop advertising or publicizing their claims of coronil being a COVID treatment until it is fully examined and approved by the Ministry of Ayush and ICMR.

Published On 2020-06-24 12:07 GMT   |   Update On 2020-06-24 12:07 GMT
Advertisement

Delhi: The Indian Council of Medical Research (ICMR) and AYUSH ministry have directed Patanjali to stop advertising and publicising its claims of its medicine 'Coronil' which it claims to be a cure for coronavirus until an approval is given by the authorities.

Recently, Patanjali claimed that Coronil is effective in curing coronavirus victims; however, the ministry of Ayush on Tuesday issued a statement saying that they have taken cognizance of the news recently flashed in the media about ayurvedic medicines developed for the treatment of COVID-19 by Patanjali, Haridwar and also added that Patanjali has failed to give any details on their scientific studies regarding the medication to the authorities. 

Advertisement

ALSO READ: Baba Ramdev claims Corona cure: All you need to know about Coronil

Hence, authorities ordered Patanjali to stop advertising or publicizing their claims of coronil being a COVID treatment until it is fully examined and approved by the Ministry of Ayush and ICMR.

Previously the Medical Dialogues team has reported that Yoga Guru Ramdev while launching Coronil said that they are "Coming up with a clinically tested, evidence-based medicine was a challenge". Patanjali claims those who administered the medicine were fully cured and none died. Ramdev even claimed that 69 percent of them recovered within 3 days. Many of the common people, as well as doctors, have been requesting ICMR to check the authenticity of Coronil. However, the ayurvedic medicines come under the authority of Ayush Ministry and they issued a statement after analyzing the claims of Patanjali. 

The ministry said, "Patanjali Ayurved Ltd has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for COVID-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined."

Moreover, as Patanjali got the license from the State authorities of Uttarakhand, "the Ministry has also requested concerned State Licensing Authority of Uttrakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19."

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News